ConductScience.org, home

Trial · NCT07877532

Serratus Anterior Plane Block for Recovery After Minimally Invasive CABG

NCT07877532, Not applicable, Not yet recruiting, Chinese PLA General Hospital

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Serratus Anterior Plane Block for Recovery After Minimally Invasive CABG. Trials, record NCT07877532. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07877532

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Serratus Anterior Plane Block for Recovery After Minimally Invasive CABG
NCT number
NCT07877532
Status
Not yet recruiting
Phases
Not applicable
Enrollment
168 participants, estimated
Lead sponsor
Chinese PLA General Hospital
Conditions
Postoperative Pain Control, Coronary Artery Disease
Interventions
Ultrasound-guided Serratus Anterior Plane Block with Ropivacaine, Ultrasound-guided Serratus Anterior Plane Block with Normal Saline
First posted
2026-10-16
Last updated
2026-10-16

Source ClinicalTrials.gov

Registered outcomes9

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryQuality of Recovery-15 (QoR-15) scorePostoperative day 1, 2, and 3 (24, 48, and 72 hours after surgery)
The QoR-15 is a 15-item questionnaire assessing postoperative recovery quality across 5 dimensions (pain, physical comfort, physical independence, psychological support, and emotional state). The total score ranges from 0 to 150, with higher scores indicating better recovery quality. It has been validated in cardiac surgery populations.
SecondaryPain intensity using the Numerical Rating Scale (NRS)Postoperative day 1, 2, and 3 (24, 48, and 72 hours after surgery)Resting and movement-evoked pain intensity assessed using an 11-point NRS (0 = no pain, 10 = worst pain imaginable).
SecondaryRescue analgesic consumptionPostoperative day 1 to 3 (within 72 hours after surgery).Total amount of rescue analgesics administered after surgery.
SecondaryIncidence and characteristics of chronic postsurgical pain (CPSP)Preoperative baseline, 1 month, and 3 months after surgery.
Assessed using the Brief Pain Inventory (BPI) and Douleur Neuropathique 4 (DN-4) questionnaire. A structured telephone interview will screen for CPSP, followed by in-person or video consultation with a pain specialist if needed. CPSP diagnosis requires: (1) pain onset after surgery or significant exacerbation; (2) duration ≥ 3 months with impact on quality of life; (3) pain after a pain-free interval or evolution from acute postoperative pain; (4) localized to surgical area or related nerve distribution; (5) exclusion of other causes.
SecondaryQuality of life assessed by EuroQol 5-Dimension 5-Level questionnaire and the EuroQol Visual Analogue Scale.Preoperative baseline, 1 month, and 3 months after surgery.
Includes the EuroQol 5-Dimension 5-Level questionnaire descriptive system (mobility, self-care, usual activities, pain/discomfort, anxiety/depression; each rated from level 1 to 5) and the EuroQol Visual Analogue Scale (EQ-VAS, 0-100, higher scores indicate better health status).
SecondaryPostoperative complications classified by the Clavien-Dindo classificationWithin 30 days after surgery.
Includes postoperative adverse events (nausea/vomiting, sleep disturbance, mood disorders, delirium) and severe complications (myocardial infarction, heart failure, respiratory failure, stroke, gastrointestinal bleeding, sepsis, reoperation, and death).
SecondaryTime to tracheal extubation within 72 hours after surgeryFrom the end of surgery until tracheal extubation, assessed up to 72 hours after surgery.Interval from the end of surgery to tracheal extubation, assessed up to 72 hours after surgery.
SecondaryTime to first active mobilization within 7 days after surgeryFrom the end of surgery until first active mobilization, assessed up to 7 days after surgery.Interval from the end of surgery to first active mobilization with or without assistance, assessed up to 7 days after surgery.
SecondaryTime to hospital discharge within 30 days after surgeryFrom the end of surgery until hospital discharge or 30 days after surgery, whichever came first, assessed up to 30 days after surgery.Number of days from the end of surgery to hospital discharge, assessed up to 30 days after surgery.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07877532

GET https://conductscience.org/api/trials/v1/NCT07877532/registered